prikaz prve stranice dokumenta Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkinʼs lymphoma patients
  Download
PDF 610.35 KB
Scientific paper - Original scientific paper
Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkinʼs lymphoma patients
Wiener klinische Wochenschrift, 134 (2022), 1-2; 80-82. https://doi.org/10.1007/s00508-021-01850-x
Lucijanić, Marko; Huzjan Korunić, Renata; Ivić, Marija; Fazlić Džankić, Amina; Jonjić, Željko; Mitrović, Zdravko; Prka, Željko; Piršić, Mario; Jakšić, Ozren; Gaćina, Petar; Vlasac Glasnović, Josipa; Pejša, Vlatko

Cite this document

Lucijanić, M., Huzjan Korunić, R., Ivić, M., Fazlić Džankić, A., Jonjić, Ž., Mitrović, Z. ... Pejša, V. (2022). Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkinʼs lymphoma patients. Wiener klinische Wochenschrift, 134. (1-2), 80-82. doi: 10.1007/s00508-021-01850-x

Lucijanić, Marko, et al. "Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkinʼs lymphoma patients." Wiener klinische Wochenschrift, vol. 134, no. 1-2, 2022, pp. 80-82. https://doi.org/10.1007/s00508-021-01850-x

Lucijanić, Marko, Renata Huzjan Korunić, Marija Ivić, Amina Fazlić Džankić, Željko Jonjić, Zdravko Mitrović, Željko Prka, et al. "Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkinʼs lymphoma patients." Wiener klinische Wochenschrift 134, no. 1-2 (2022): 80-82. https://doi.org/10.1007/s00508-021-01850-x

Lucijanić, M., et al. (2022) 'Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkinʼs lymphoma patients', Wiener klinische Wochenschrift, 134(1-2), pp. 80-82. doi: 10.1007/s00508-021-01850-x

Lucijanić M, Huzjan Korunić R, Ivić M, Fazlić Džankić A, Jonjić Ž, Mitrović Z, and sur.. Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkinʼs lymphoma patients. Wiener klinische Wochenschrift [Internet]. 2022 January [cited 2024 April 15];134(1-2):80-82. doi: 10.1007/s00508-021-01850-x

M. Lucijanić, et al., "Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkinʼs lymphoma patients", Wiener klinische Wochenschrift, vol. 134, no. 1-2, pp. 80-82, January 2022. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:353460. [Accessed: 15 April 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)Psoas muscle index at the time of diagnosis might reflect the prognosis of classical Hodgkinʼs lymphoma patients
AuthorMarko Lucijanić
AuthorRenata Huzjan Korunić
AuthorMarija Ivić
AuthorAmina Fazlić Džankić
AuthorŽeljko Jonjić
AuthorZdravko Mitrović
AuthorŽeljko Prka
AuthorMario Piršić
AuthorOzren Jakšić
AuthorPetar Gaćina
AuthorJosipa Vlasac Glasnović
AuthorVlatko Pejša
Author's institutionUniversity of Zagreb
School of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (english)
We retrospectively investigated clinical and prognostic significance of psoas muscle index (PMI) calculated as total psoas muscle area at L3 vertebra level obtained from baseline computed tomography (CT) scans in 49 newly diagnosed classical Hodgkin's lymphoma (cHL) patients prior to specific treatment. Median PMI was 572.5 mm2/m2 and was significantly higher in males (P < 0.001), patients with higher body mass index (BMI, P < 0.001), absence of extranodal disease (P = 0.037), higher absolute lymphocyte count (P = 0.037), higher hemoglobin (P = 0.010) and lower lactate dehydrogenase (LDH, P = 0.050). There were no significant associations with age, disease subtype, presence of constitutional symptoms, Ann Arbor disease stage, presence of advanced disease or international prognostic score. Patients with lower PMI had significantly worse PFS (hazard ratio [HR] 4.91; P = 0.009). This phenomenon persisted in the multivariate model (HR = 5.09; P = 0.042) adjusted for International Prognostic Score (IPS) and chemotherapy type.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review
Publication versionAccepted version
Journal titleWiener klinische Wochenschrift
Numberingvol. 134, no. 1-2, pp. 80-82
p-ISSN0043-5325
e-ISSN1613-7671
DOIhttps://doi.org/10.1007/s00508-021-01850-x
URN:NBNurn:nbn:hr:105:353460
Publication2022-01
Document URLhttps://link.springer.com/10.1007/s00508-021-01850-x
Type of resourceText
Access conditionsOpen access
Embargo expiration date: 2023-02-01
Terms of useLicence In copyright icon
Created on2022-02-18 09:15:31